affected to the slowdown of Thailand economic activities at almost of every sector both for consume and investment of the private sector as well as the high shrinkage of the production from industrial sector
from non-social security patients which generated high margin and the increase of social security payment rate in the first half of year 2018. Moreover, the efficient cost management such as medicine
(raw material), COGs/revenue ratio of Q1/2019 are at high level. This is because of high stock level carried over Q4/2018. Increase in cost of sales of are main impact to minus in bottom line. 3 / 4
due to the high fiscal base effect in the same period last of year that have accelerated disbursement after the budget Act for the year 2020 was delayed, it remained at a high level. In Q1–2021, the
. The operating results of the Company and its subsidiaries continued to improve, with total revenue and profit at baht 67,423.88 million and baht 6,176.59 million respectively, an increase of 2.08% and
profit of THB 350. 79 million or earnings per share of THB 0. 35 in 2016, a decrease of THB 117.54 million or 33.51%. Details were as follows: Operating results 2017 2016 Increase (Decrease) % Real Estate
follows; Performance Highlights for Q1/2019 Net Profit attributed to Equity Shareholders was 144.5 million Baht, increased 24.5% from the same period last year and increase 9.5% from Q4/2018. This
consumption recovery and the high household debt. The Company keeps focusing on house brand products to emphasize FN brand awareness and increase FN brand equity in a long run. The Company was able to maintain
level. In addition, there was an increase of reduction cost of inventory to net realizable value amounting of Baht 3.0 million in Q2/2017, whereas there was no such transaction in Q2/2016. The interest